+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Germany Sexually Transmitted Diseases (STD) Diagnostics Market 2019-2025

  • ID: 5116804
  • Report
  • February 2020
  • Region: Germany
  • Orion Market Research Private Limited

FEATURED COMPANIES

  • Abbott Laboratories, Inc.
  • AbbVie Inc.
  • Becton, Dickinson and Co.
  • Biocartis NV
  • Danaher Corp.
  • Eli Lilly and Co.
Germany Sexually Transmitted Diseases (STD) Diagnostics Market Size, Share & Trends Analysis Report by Disease Type (Chlamydia, Syphilis, Gonorrhea, Herpes Simplex Virus (HSV), Human Papilloma Virus (HPV), Human Immunodeficiency Virus (HIV), and Others), by Product (Laboratory Testing Devices, and Point-of-Care (POC) Testing Devices) by End-user (Hospitals and Clinics, Diagnostic Centers, and Homecare) Forecast Period 2019-2025.

Germany STD diagnostics market is growing at a CAGR of around 7.9% during the forecast period. Germany STD diagnostics market is growing due to the factors including the most important of which is the government support towards health of the public. Health insurance is one of the major guidelines enforced by government of Germany.

Health insurance is mandatory for all citizens and permanent residents of Germany. It is provided by two systems, that is competing, not-for-profit, nongovernmental health insurance funds in the statutory health insurance (SHI) system and substitutive private health insurance (PHI). States own most university hospitals, while municipalities play a role in public health activities and own about half of all hospital beds. Though, the various levels of governments have virtually no role in the direct financing or delivery of health care, these health insurances insure the people of any critical illness such as cancer, STDs and so on, which is anticipated to influence the growth of the Germany STD diagnostics market during the forecast period.

Syphilis is a type of STIs contracted through sexual contact and as from mother to child at birth. The country’s Syphilis average was more than 7.1 cases for every 100,000 residents. Syphilis prevalence among MSM has been on the rise during the last few years. Further, HIV treatment has been made available in Germany for preventing the onset of AIDS and enabling people with HIV to live longer and healthier lives.

However, it is estimated that more than 1000 people in Germany every year develop AIDs due to late diagnosis or due to inability to have an access to the treatment. The Kein AIDS für Alle campaign has been launched in Germany to remove the stigma and discrimination around HIV and encouraging key populations to have an access to HIV prevention, testing, treatment and care services through innovative initiatives. The support will be provided to the doctors for improving the timely diagnosis of HIV, and in turn affects the Germany STD diagnostics market.

Research Methodology:

The market study of the Germany STD Diagnostics market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. The research team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables the analyst to derive the closest possible figures without any major deviations in the actual number. The analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to the reports.

Secondary Sources Include:
  • Financial reports of companies involved in the market.
  • Whitepapers, research-papers, and news blogs.
  • Company websites and their product catalog.

The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation:

1. Germany STD Diagnostics Market Research and Analysis by Disease Type
2. Germany STD Diagnostics Market Research and Analysis by Product
3. Germany STD Diagnostics Market Research and Analysis by End-user

The Report Covers:
  • Comprehensive Research Methodology of the Germany STD Diagnostics market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the Germany STD Diagnostics market.
  • Insights about market determinants which are stimulating the Germany STD Diagnostics market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Abbott Laboratories, Inc.
  • AbbVie Inc.
  • Becton, Dickinson and Co.
  • Biocartis NV
  • Bio-Rad Laboratories, Inc.
  • Danaher Corp.
  • Eli Lilly and Co.
  • F. Hoffmann-La Roche Ltd.
  • Merck KGaA
  • Thermo Fisher Scientific, Inc.
Note: Product cover images may vary from those shown